Skip to main content

Indian pharma Industry must comply with govt deadline to upgrade staff skill

 

Clinical courses

The Indian pharmaceutical industry must consider the January 1, 2018 deadline issued by the Comptroller General of India Drugs (DCGI) as sacrosanct to improve the skills of people employed in their units, according to the Life Sciences Sector Skill Development Council (LSSSDC) set up under the auspices of the Ministry of Skills Development.

"The Indian workforce is 3.7% in terms of National Occupancy Standards, compared with 97% in South Korea and 50% in China. The developed countries also have a very high rate because the low rate exceeds other factors in the economy that we can not compromise on the same, "said Ranjit Madan, CEO of the Science Skills Development Council Of life, while speaking at the launch of the Skills Development Project in the state of Maharashtra.

"Given the objective of substantially improving the quality of pharmaceutical products, it has become imperative that all staff employed in pharmaceutical manufacturing units undergo the certification programs developed by the LSSSDC and from January 1, 2018, Employed in any pharmaceutical / bio-pharmaceutical manufacturing unit unless he has obtained an official degree in the area concerned or has been certified by the LSSSDC or an equivalent organization in the region where in which he has been deployed,” the DCGI circular then said.

In Maharashtra, LSSSDC mandated Pollux Life Science Solutions LLP led by Hemant Deshpande to lead broad base skills, starting at the undergraduate level of pharmacy and concluding with the specific employment theory and practical training of ten major roles Which covers 90% of the functions in the pharmaceutical company.

 

"Indian pharmaceutical professionals record salaries worth Rs 33,000 per year and this is largely dependent on export earnings. Any element of neglect at different levels of the workforce can threaten regulatory reactions hindering the image of society in particular and the country in general, "said Deshpande.

"India is exporting $ 17 billion worth of pharmaceutical drugs and one out of two drugs consumed in the world is by an Indian," said Dr Bangarurajan, Assistant West Medicines Controller. The country also produces 50,000 pharma graduates each year of which 7,000 are from Maharashtra. However, in 2016, 136 export alert letters were issued worldwide and India accounted for 27% of the same, which threatens to reduce revenue growth and needs to be addressed through training programs.”

The launch was attended by industry leaders from across the pharma spectrum including Vivek Padagaonkar and Rajiv Shukla from the Organization of Pharmaceutical Producers of India (OPPI) and Dr. George Patani from the Indian Drug Manufacturers Association (IDMA)

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email